Publicaciones científicas

22 Publicaciones científicas disponibles

  • Immunologic characterization of COVID-19 patients with hematological cancer

    17 de diciembre de 2020 | Revista: Haematologica

    Catarina Maia  1 , Esperanza Martín-Sánchez  1 , Juan José Garcés  1 , Ascensión López-Díaz De Cerio  2 , Susana Inogés  2 , Manuel F Landecho  3 , Belén Gil-Alzugaray  4 , Cristina Perez  5 , Cirino Botta  6 , Aintzane Zabaleta  1 , Félix Alegre  3 , César Rincón  4 , Laura Blanco  7 , Sarai Sarvide  5 , Amaia Vilas-Zornoza  8 , Diego Alignani  1 , Cristina Moreno  9 , Artur Paiva  10 , António Martinho  11 , Rui Alves  10 , Enrique Colado  12 , Covadonga Quirós  12 , Mónica Olid  4 , Andrés Blanco  3 , Josepmaria Argemi  13 , Bruno Paiva  1 , José Ramón Yuste  14


  • EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

    12 de septiembre de 2019 | Revista: Hepatology

    Gouya L (1), Ventura P (2), Balwani M (3), Bissell DM (4), Rees DC (5), Stölzel U (6), Phillips JD (7), Kauppinen R (8), Langendonk JG (9), Desnick RJ (3), Deybach JC (1), Bonkovsky HL (10), Parker C (7), Naik H (3), Badminton M (11), Stein PE (5), Minder E (12), Windyga J (13), Bruha R (14), Cappellini MD (15), Sardh E (16), Harper P (16), Sandberg S (17), Aarsand AK (17), Andersen J (17), Alegre F (18), Ivanova A (19), Talbi N (20), Chan A (21), Querbes W (21), Ko J (21), Penz C (21), Liu S (21), Lin T (21), Simon A (21), Anderson KE (22).

    (1) Centre de Référence Maladies Rares Porphyries, Colombes, France.
    (2) Università degli Studi di Modena e Reggio Emilia, Emilia-Romagna, Italy.
    (3) Icahn School of Medicine at Mount Sinai, New York, NY, USA.
    (4) University of California, San Francisco, CA, USA.
    (5) King's College Hospital, King's College London, London, UK.
    (6) Klinikum Chemnitz Porphyria Center, Chemnitz, Germany.
    (7) University of Utah, Salt Lake City, UT, USA.
    (8) University Hospital of Helsinki, Helsinki, Finland.
    (9) Porphyria Center, Center for Lysosomal and Metabolic Disease, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
    (10) Section on Gastroenterology & Hepatology, Wake Forest University/NC Baptist Medical Center, Winston-Salem, NC, USA.
    (11) University Hospital of Wales, Cardiff, UK.
    (12) Stadtspital Triemli, Zentrallabor, Zurich, Switzerland.
    (13) Department of Hemostatic Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
    (14) 4th internal clinic, General University Hospital, Charles University, Prague, Czech republic.
    (15) University of Milan, Fondazione IRCCS, Ca Granda, Milan, Italy.
    (16) Porphyria Centre Sweden, Centre for Inherited Metabolic Diseases, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
    (17) Norwegian Porphyria Centre, Haukeland University Hospital, Bergen, Norway.
    (18) Clinica Universidad de Navarra, Navarra, Spain.
    (19) St. Ivan Rilski U Hospital, Sofia, Bulgaria.
    (20) Laboratory of Excellence GR-Ex, University of Paris, Paris, France.
    (21) Alnylam Pharmaceuticals, Cambridge, MA, USA.
    (22) University of Texas Medical Branch, Galveston, TX, USA


  • Lercanidipine-induced chylous ascites: Case report and literature review

    2 de octubre de 2017 | Revista: Journal of Clinical of Pharmacy Therapeuthics

    Basualdo JE (1), Rosado IA (1), Morales MI (2), Fernández-Ros N (1), Huerta A (1), Alegre F (1), Landecho MF (1), Lucena JF (1).

    (1) Division of Intermediate Care and Hospitalists Unit, Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Department of Nuclear Medicine, Clínica Universidad de Navarra, Pamplona, Spain.


  • Comment on "Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit" by Benoît Dupont et al. [Digestive and Liver Disease 2015;47:675-81].

    1 de febrero de 2016 | Revista: Digestive and Liver Disease

    Alegre F (1), Huerta A (2), Landecho MF (2), Lucena JF (2).
    (1) Division of Intermediate Care and Hospitalists Unit, Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Navarra, Spain. Electronic address: falegre@unav.es.
    (2) Division of Intermediate Care and Hospitalists Unit, Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Navarra, Spain. 

SOLICITE